131 related articles for article (PubMed ID: 15272596)
1. [Tamoxifen-induced severe hypertriglyceridemia--report of 3 cases].
Koshizuka K; Serizawa M; Hasuda N; Furuya K; Mouri N; Takano K; Matsumoto M
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1109-12. PubMed ID: 15272596
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen-induced hypertriglyceridemia in association with diabetes mellitus.
Milionis HJ; Liberopoulos EN; Elisaf MS
Diabetes Metab; 2001 Apr; 27(2 Pt 1):160-3. PubMed ID: 11353883
[TBL] [Abstract][Full Text] [Related]
3. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
4. Effect of anastrozole and tamoxifen on lipid metabolism in Japanese postmenopausal women with early breast cancer.
Sawada S; Sato K; Kusuhara M; Ayaori M; Yonemura A; Tamaki K; Hiraide H; Mochizuki H; Ohsuzu F
Acta Oncol; 2005; 44(2):134-41. PubMed ID: 15788292
[TBL] [Abstract][Full Text] [Related]
5. Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.
Berry J
Clin Ther; 2005 Nov; 27(11):1671-84. PubMed ID: 16368441
[TBL] [Abstract][Full Text] [Related]
6. Incidence and management of side effects associated with aromatase inhibitors in the adjuvant treatment of breast cancer in postmenopausal women.
Mouridsen HT
Curr Med Res Opin; 2006 Aug; 22(8):1609-21. PubMed ID: 16870085
[TBL] [Abstract][Full Text] [Related]
7. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
[TBL] [Abstract][Full Text] [Related]
8. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
Boccardo F; Rubagotti A; Puntoni M; Guglielmini P; Amoroso D; Fini A; Paladini G; Mesiti M; Romeo D; Rinaldini M; Scali S; Porpiglia M; Benedetto C; Restuccia N; Buzzi F; Franchi R; Massidda B; Distante V; Amadori D; Sismondi P
J Clin Oncol; 2005 Aug; 23(22):5138-47. PubMed ID: 16009955
[TBL] [Abstract][Full Text] [Related]
9. The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancer.
Banerjee S; Pancholi S; A'hern R; Ghazoui Z; Smith IE; Dowsett M; Martin LA
Clin Cancer Res; 2008 May; 14(9):2656-63. PubMed ID: 18451229
[TBL] [Abstract][Full Text] [Related]
10. Effects of toremifene (TOR) and tamoxifen (TAM) on serum lipids in postmenopausal patients with breast cancer.
Kusama M; Miyauchi K; Aoyama H; Sano M; Kimura M; Mitsuyama S; Komaki K; Doihara H
Breast Cancer Res Treat; 2004 Nov; 88(1):1-8. PubMed ID: 15538040
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.
Smith IE; Dowsett M; Ebbs SR; Dixon JM; Skene A; Blohmer JU; Ashley SE; Francis S; Boeddinghaus I; Walsh G;
J Clin Oncol; 2005 Aug; 23(22):5108-16. PubMed ID: 15998903
[TBL] [Abstract][Full Text] [Related]
12. [Rare cause for severe hypertriglyceridemia - case 9/2013].
Kahl S; Roden M; Mörike K; Müssig K
Dtsch Med Wochenschr; 2013 Nov; 138(47):2410. PubMed ID: 24221976
[TBL] [Abstract][Full Text] [Related]
13. Ocular toxicity during adjuvant chemoendocrine therapy for early breast cancer: results from International Breast Cancer Study Group trials.
Gianni L; Panzini I; Li S; Gelber RD; Collins J; Holmberg SB; Crivellari D; Castiglione-Gertsch M; Goldhirsch A; Coates AS; Ravaioli A;
Cancer; 2006 Feb; 106(3):505-13. PubMed ID: 16369994
[TBL] [Abstract][Full Text] [Related]
14. Granulosa cell tumor of the ovary associated with antecedent tamoxifen use.
Gherman RB; Parker MF; Macri CI
Obstet Gynecol; 1994 Oct; 84(4 Pt 2):717-9. PubMed ID: 9205462
[TBL] [Abstract][Full Text] [Related]
15. Severe hypertriglyceridemia caused by tamoxifen-treatment after breast cancer surgery.
Hozumi Y; Kawano M; Miyata M
Endocr J; 1997 Oct; 44(5):745-9. PubMed ID: 9466333
[TBL] [Abstract][Full Text] [Related]
16. Biomarker changes during neoadjuvant anastrozole, tamoxifen, or the combination: influence of hormonal status and HER-2 in breast cancer--a study from the IMPACT trialists.
Dowsett M; Ebbs SR; Dixon JM; Skene A; Griffith C; Boeddinghaus I; Salter J; Detre S; Hills M; Ashley S; Francis S; Walsh G; Smith IE
J Clin Oncol; 2005 Apr; 23(11):2477-92. PubMed ID: 15767642
[TBL] [Abstract][Full Text] [Related]
17. Ameliorating effect of coenzyme Q10, riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins.
Yuvaraj S; Premkumar VG; Vijayasarathy K; Gangadaran SG; Sachdanandam P
Clin Biochem; 2007 Jun; 40(9-10):623-8. PubMed ID: 17425952
[TBL] [Abstract][Full Text] [Related]
18. Improved overall survival in postmenopausal women with early breast cancer after anastrozole initiated after treatment with tamoxifen compared with continued tamoxifen: the ARNO 95 Study.
Kaufmann M; Jonat W; Hilfrich J; Eidtmann H; Gademann G; Zuna I; von Minckwitz G
J Clin Oncol; 2007 Jul; 25(19):2664-70. PubMed ID: 17563395
[TBL] [Abstract][Full Text] [Related]
19. Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia with positive rechallenge.
Sakhri J; Ben Salem C; Harbi H; Fathallah N; Ltaief R
JOP; 2010 Jul; 11(4):382-4. PubMed ID: 20601815
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E4 allele influences the response of plasma triglyceride levels to tamoxifen in breast cancer patients.
Chang NW; Chen FN; Wu CT; Lin CF; Chen DR
Clin Chim Acta; 2009 Mar; 401(1-2):144-7. PubMed ID: 19103187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
